Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02552732 · ClinicalTrials.gov registry record · NA
Nasal High Flow Therapy 30 Day Readmission Study
A NA study, sponsored by Fisher and Paykel Healthcare.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT02552732: Clinical Trial NA study, sponsored by Fisher and Paykel Healthcare.
NCT02552732 is a NA study that was terminated before completion, run by Fisher and Paykel Healthcare. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02552732, a NA study, was terminated before completion, sponsored by Fisher and Paykel Healthcare.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The aim of this feasibility study is to provide data for a subsequent randomized controlled trial to investigate if patient outcomes will be improved after an acute COPD exacerbation using domiciliary nasal high flow therapy (NHF) compared to standard care. This feasibility study will investigate the following: process, resources, management and scientific aspects of delivering NHF as an adjunct therapy in COPD patients.
Primary Outcome
Use will be expressed as hours of myAIRVO 2 use per day over 30 days, as obtained by myAIRVO 2 electronic monitoring
Interventions
- DEVICE NHF with or without Oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-05-03 |
| Phase | NA |
Why NCT02552732 stopped before completion
NCT02552732 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which NHF with or without Oxygen is the first listed.
NCT02552732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02552732 about?
NCT02552732 is a clinical study titled "Nasal High Flow Therapy 30 Day Readmission Study". The aim of this feasibility study is to provide data for a subsequent randomized controlled trial to investigate if patient outcomes will be improved after an acute COPD exacerbation using domiciliary nasal high flow therapy (NHF) compared to standard care. This feasibility study will investigate th...
What is the current status of trial NCT02552732?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2015-11. Estimated completion is 2017-05-03.
What interventions are being tested in trial NCT02552732?
The interventions under investigation include: NHF with or without Oxygen (DEVICE).
Who is sponsoring clinical trial NCT02552732?
This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02552732's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia